Prosopagnosia
Introduction of Prosopagnosia
Prosopagnosia can be developed or acquired. Some of the most common causes of acquired prosopagnosia include destructive conditions such as posterior cerebral artery stroke or hematoma. Developmental prosopagnosia (DP) is a cognitive disorder characterized by severe facial recognition defects without any known impairments, neurological diseases, or low-level visual or intellectual impairments. It is estimated that about 2% of adults and children have experienced DP or “face blindness”. This situation can seriously affect daily life, and even produce devastating consequences, such as avoiding social interactions, interpersonal problems, damage to careers, and even depression.
Prosopagnosia is Related to Cortical Damage
Damage to specific areas of the cerebral cortex leads to many high visual processing disorders, which have specific roles in processing certain aspects of vision. Face recognition is supported by the collaboration of multiple facial reaction areas in the brain. A neural model is proposed based on the normal face recognition brain area, the occipital face area (OFA), the fuzzy face area (FFA), and the face-selective posterior superior temporal sulcus (pSTS) are used as the core face network (CFN), and the rest of the face response area serves as an extended surface network (EFN). By exploring the resting functional connection (FC) between the facial response areas of patients with DPs, we found that these interrupted FCs are related to DP's behavioral defects in face recognition.
Fig.1 FMRI diagram of DPs and normal core face network (CFN). (Zhao, 2018)
NMDA Receptor Play a Role in Prosopagnosia
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disease that exhibits various neurological symptoms, including behavioral changes, memory deficits, seizures, and static form prosopagnosia. The patient can recognize the form of moving objects, but not the form of stationary objects. NMDA receptor encephalitis involves antibodies against the GluN1 subunit of the NMDA receptor. These antibodies may cause the binding, capping, and cross-connection of NMDA receptors, leading to the internalization of neuronal membrane surface receptors, and the dysfunction of signal transmission mediated by glutamine synapses. Therefore, drug mediated signaling pathways related to NMDA receptors may be available regulatory pathways for the treatment of prosopagnosia.
Fig.2 Cognitive network affected by NMDAR dysfunction. (Dalmau, 2016)
Creative Biolabs has many reliable protein/peptides, neurotransmitter, and antibody products in the field of neuroscience,it may be a useful reagent for your research on prosopagnosia and related neuroencephalitis.
Product Name | Biological Activity | Target | Cat.NO. |
ACBC [NMDA Agonist] | Agonist | NMDA Receptor | MOD2005ZP369 |
Amantadine hydrochloride [NMDA Antagonist] | Antagonist | NMDA Receptor | MOD2005ZP370 |
Mouse Anti-GluN1/NR1 Monoclonal Antibody (NS308-48) | WB / IHC / ICC / IF | GRIN1/NMDAR1 | NAB2007FY693 |
Recombinant Human GRIN1 Protein (N-GST) | ELISA / SDS-PAGE / WB | GRIN1/NMDAR1 | NPR2008PZ1542 |
If you need any customized services or products, please feel free to contact us.
References
- Zhao, Y.; et al. The neural network for face recognition: Insights from an fMRI study on developmental prosopagnosia. NeuroImage. 2018, 169: 151-161.
- Dalmau, J. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture. Neurology. 2016, 87(23): 2471-2482.
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Rat Muller Cell (Cat#: NCL2110P040)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)